Anti-Aging · Reference
Can You Take Ipamorelin + Sermorelin With Tirzepatide or Semaglutide?
This page is about the paired vial specifically. The single-molecule versions are in can you take sermorelin with tirzepatide and can you take ipamorelin with tirzepatide. Everything here applies to semaglutide the same way.
Ipamorelin + Sermorelin can be prescribed alongside tirzepatide or semaglutide, and when it is, the reason is usually lean tissue, not more weight loss. The vial carries two growth hormone signals at two pituitary receptors, while tirzepatide and semaglutide act on gut-hormone receptors, so they do not overlap. No study has tested the combination, and no trial shows a growth hormone secretagogue preserves muscle during GLP-1 treatment. The points worth knowing are appetite, because ipamorelin acts at the receptor the hunger hormone ghrelin uses, and glucose, because growth hormone reduces insulin sensitivity while GLP-1 medications act the other way.
This page is about the paired vial specifically. The single-molecule versions are in can you take sermorelin with tirzepatide and can you take ipamorelin with tirzepatide. Everything here applies to semaglutide the same way.
Can You Take Ipamorelin + Sermorelin With Tirzepatide or Semaglutide?
The short answer
| Question | Answer |
|---|---|
| Can they be prescribed together? | Yes, after a physician reviews your intake |
| Why pair them? | Lean tissue, as an adjunct to resistance training and a protein target |
| Has the combination been studied? | No. Ipamorelin + Sermorelin has never been studied as a blend, let alone with a GLP-1 |
| Does the vial add weight loss? | No trial shows that. Sermorelin trials that measured weight found no change, and a mouse study of ipamorelin reported more food intake and fat |
| Where do they pull in opposite directions? | Appetite, gastric emptying in animal work, and glucose |
| What gets watched? | Glucose, and how your appetite responds in the evening |
| Same answer for semaglutide? | Yes |
The products this page covers:
| Product | What is in it | Typical directions | Price |
|---|---|---|---|
| Ipamorelin + Sermorelin | 5 mL vial, ipamorelin 2 mg/mL + sermorelin 2 mg/mL (10 mg of each) | 0.25 mL (25 units) under the skin Monday through Friday nights at bedtime | $219/mo |
| Tirzepatide | Dose-specific 2 mL vials, 10 mg to 60 mg per vial for weekly strengths of 2.5 mg to 15 mg; glycine in the 2.5 mg and 7.5 mg vials | 0.50 mL (50 units) once weekly | From $159/mo |
| Semaglutide | Dose-specific vials, 1 mg to 10 mg per vial | Printed on the vial for your strength | From $99/mo |
Prices are all-in, covering medication, physician review, refill management and shipping, with no membership fee. GLP-1 prices are "from" prices, set by dose. Pepti is cash-pay and does not bill insurance. Compounded medications are not FDA approved.
Can You Take Ipamorelin + Sermorelin With Tirzepatide or Semaglutide?
What each medication is
Tirzepatide and semaglutide
Tirzepatide is a single peptide that activates the GIP and GLP-1 receptors; semaglutide activates the GLP-1 receptor alone. Both act on appetite centres in the brain, slow gastric emptying and change insulin and glucagon signalling. More is in what is tirzepatide and semaglutide vs tirzepatide.
Ipamorelin + Sermorelin
This is two peptides in equal amounts in one vial. Sermorelin is a synthetic copy of the first 29 amino acids of growth-hormone-releasing hormone (GHRH), the "go" signal the hypothalamus sends to the pituitary. Ipamorelin is a five-amino-acid peptide that acts at the ghrelin receptor, which amplifies the growth hormone pulse. Each dose of 0.25 mL delivers 0.5 mg of each, fixed 1:1. Neither contains growth hormone; both are signals to your own pituitary, with somatostatin and IGF-1 feedback still in place. The full reference is what is Ipamorelin + Sermorelin.
Side by side
Tirzepatide or semaglutide Ipamorelin + Sermorelin Receptors GLP-1, and GIP for tirzepatide GHRH receptor (sermorelin) and ghrelin receptor (ipamorelin) Appetite Reduced Ipamorelin acts at the hunger hormone's receptor; some people report more appetite Gastric emptying Slowed Faster in rat studies of ipamorelin Glucose direction Improves insulin signalling Growth hormone reduces insulin sensitivity Human evidence Large randomised trials of the approved products Per component only; the blend has never been studied Schedule at Pepti Once weekly Monday through Friday nights at bedtime
Can You Take Ipamorelin + Sermorelin With Tirzepatide or Semaglutide?
Why anyone pairs the two
Weight lost on a GLP-1 is not all fat. In the STEP 1 body-composition substudy of semaglutide, both fat mass and lean mass fell, though fat fell by more. Strong appetite suppression also makes under-eating protein easy. That is the rationale prescribers give for adding a growth-hormone-axis peptide: something aimed at lean tissue, used with resistance training and a protein target, not instead of them.
What the pairing does not have is evidence that it works. No trial shows a growth hormone secretagogue preserves lean mass during GLP-1 treatment. The closest human data is on sermorelin alone: a 1997 trial of a closely related GHRH(1-29) analogue in nineteen adults aged 55 to 71 reported more lean mass in men only after 16 weeks, and a six-week trial in eleven older men found no change in body composition. Ipamorelin has no human body-composition data at all.
Can You Take Ipamorelin + Sermorelin With Tirzepatide or Semaglutide?
The three places they pull in opposite directions
1. Appetite
This is the point that separates the paired vial from sermorelin alone. Sermorelin on its own is not usually associated with appetite change. Ipamorelin acts at the receptor ghrelin uses to signal hunger, and hunger after the injection is one of the effects prescribers report. In a 2001 mouse study, twice-daily ipamorelin increased body weight, fat-pad weight and food intake. There are no human data either way, but alongside a GLP-1 it runs against what the GLP-1 is doing. Bedtime dosing means any hunger tends to arrive as you go to sleep. It is not dangerous, but report it if it interferes with your goal; it is one reason a physician may prefer sermorelin alone for someone on a GLP-1.
2. Gastric emptying
Ghrelin receptors also sit on the nerves that drive stomach and intestinal movement. In rats, ipamorelin sped gastric emptying. Tirzepatide and semaglutide slow it, which is the source of most of their stomach side effects. Nobody has studied what the two do together, and in the one randomised human trial of ipamorelin, given intravenously after bowel surgery, it did not separate from placebo. So the rat effect has not been shown in people.
3. Glucose
Growth hormone raises blood glucose by reducing tissue sensitivity to insulin, and the secretagogue literature names rising glucose as its recurring concern. GLP-1 medications act the other way. In the published sermorelin trials fasting glucose was unchanged, but the effect is larger when glucose handling is already strained. Separately, tirzepatide on its own rarely causes low blood glucose, but the risk rises with insulin or a sulfonylurea. Every glucose-lowering medication goes on the intake.
Can You Take Ipamorelin + Sermorelin With Tirzepatide or Semaglutide?
Telling the side effects apart
| Symptom | More likely from | What to do |
|---|---|---|
| Nausea, reflux, constipation, diarrhoea | The GLP-1, mostly around dose increases | Message your care team if it is not settling |
| Flushing or warmth shortly after the bedtime dose | Sermorelin | Usually settles; report it if marked |
| Hunger after the injection | Ipamorelin | Report it if it affects your goal |
| Vivid dreams | Evening growth-axis dosing | Report it if it persists |
| Headache in the first weeks | Either | Report it if it persists |
| Puffy hands or ankles, joint aches, tingling hands | The growth hormone side; the recognised pattern of growth hormone above your requirement | Message your care team; do not change the dose yourself |
| Severe abdominal pain, often radiating to the back | The GLP-1; a possible pancreatitis presentation | Seek care promptly |
| Facial or throat swelling, widespread rash, breathing difficulty | Either, rarely | Call 911 first, then tell your physician |
Starting the paired vial in the same week as a GLP-1 dose step makes this table harder to use, because a new symptom then has two plausible causes. More is in ipamorelin side effects, is sermorelin safe and GLP-1 side effects.
Can You Take Ipamorelin + Sermorelin With Tirzepatide or Semaglutide?
Fitting the schedules together
| Ipamorelin + Sermorelin | Tirzepatide | |
|---|---|---|
| Draw | 0.25 mL (25 units on a U-100 insulin syringe) | 0.50 mL (50 units) |
| Medication per dose | 0.5 mg ipamorelin and 0.5 mg sermorelin | Your weekly strength |
| How often | Monday through Friday nights at bedtime | Once weekly, same day each week |
| Doses per vial | 20 | 4 |
| One vial lasts | About four weeks | Four weeks |
The paired-vial figures are math from the label: 0.25 mL of a 2 mg/mL solution is 0.5 mg of each peptide, and 5 mL at 0.25 mL is 20 doses, five nights a week for four weeks. Both run on a 28-day refill cycle, one vial per fill.
- Two vials, two syringes, two sites. Never mix them in one syringe; each label was calculated against that vial's concentration.
- Bedtime is part of the schedule. The largest natural growth hormone pulse arrives in the first hours of sleep.
- Keep your GLP-1 day fixed, and use a different site on a shared day.
Dose detail is in Ipamorelin + Sermorelin dosage.
Can You Take Ipamorelin + Sermorelin With Tirzepatide or Semaglutide?
What not to stack
| Combination | Why not |
|---|---|
| Ipamorelin + Sermorelin with a separate ipamorelin or sermorelin vial | Duplicates a component already in the vial |
| Ipamorelin + Sermorelin with CJC-1295 / Ipamorelin, tesamorelin or a blend such as ASCEND, TITAN or PHYSIQ | A second GHRH analogue and more ipamorelin: more signal at the same receptors, not a new mechanism |
| Tirzepatide with semaglutide | Both act at the GLP-1 receptor; stacked side effects with nothing gained |
| Anything bought as "research use only" | Nobody is accountable for identity, purity, sterility or concentration |
Can You Take Ipamorelin + Sermorelin With Tirzepatide or Semaglutide?
Who should discuss it first
| Situation | Why |
|---|---|
| Diabetes or impaired glucose tolerance | Growth hormone can raise blood glucose |
| Insulin or a sulfonylurea | Low blood glucose on tirzepatide becomes more likely |
| Personal history of cancer | Growth hormone and IGF-1 support the growth of any tissue |
| Personal or family history of medullary thyroid carcinoma or MEN 2 | Rules out tirzepatide and semaglutide |
| Pregnancy, planning pregnancy or breastfeeding | Neither is used |
| Tested athlete | Both ipamorelin and sermorelin are prohibited at all times; see is Ipamorelin + Sermorelin banned in sports |
Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
Can You Take Ipamorelin + Sermorelin With Tirzepatide or Semaglutide?
What the evidence shows, honestly
Tirzepatide and semaglutide have a very large human evidence base in their FDA-approved forms; the compounded versions share the active ingredients, and the trial data belongs to the manufactured products. Sermorelin has a paediatric trial programme from its former approval and three small controlled studies in healthy older adults. Ipamorelin has a pharmacokinetic study in healthy men and one intravenous surgical trial that did not meet its endpoint. The blend has never been studied, and no trial has combined any growth hormone secretagogue with a GLP-1 to measure muscle. Anyone presenting the pairing as shown to protect lean mass is overstating what exists.
On the FDA side, sermorelin was the active ingredient of a product approved in 1990 and 1997 and discontinued in 2008, and in 2013 the FDA determined the withdrawal was not for reasons of safety or effectiveness. Ipamorelin was placed in Category 2 in 2023, an advisory committee voted against adding it to the 503A bulks list in October 2024, and it sits in no 503A category on the list updated 14 May 2026, with no final determination issued. Compounded Ipamorelin + Sermorelin is not FDA approved.
Can You Take Ipamorelin + Sermorelin With Tirzepatide or Semaglutide?
How to add Ipamorelin + Sermorelin to a GLP-1 plan
- Complete a free online intake covering your history, every medication including any glucose-lowering drug, and what you want help with. "I am worried about losing muscle" gives your physician more to work with than a product name.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares each prescription. Lot test results are published at /quality/lab-results.
- Each vial ships refrigerated with ice packs, ready to use, with sterile syringes and alcohol prep pads and its directions printed on the vial.
- Refills run every 28 days, one vial per fill, and your care team stays reachable for questions and side effects.
Your physician sets your directions after reviewing your intake. Step by step: how to get Ipamorelin + Sermorelin prescribed online and how to get tirzepatide prescribed online. The wider picture is in what peptides can you take with tirzepatide.
References
What this is based on.
References
- Raun K, Hansen BS, Johansen NL et al.. Ipamorelin, the first selective growth hormone secretagogue · Eur J Endocrinol (1998) · PMID 9849822
- Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? · Clin Interv Aging (2006) · PMID 18046908
- Tiulpakov AN, Brook CG, Pringle PJ et al.. GH responses to intravenous bolus infusions of GH releasing hormone and GH releasing peptide 2 separately and in combination in adult volunteers · Clin Endocrinol (Oxf) (1995) · PMID 7586605
- Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues · Sex Med Rev (2018) · PMID 28400207
- Wilding JPH, Batterham RL, Calanna S, et al.. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) · New England Journal of Medicine (2021) · PMID 33567185
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al.. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) · New England Journal of Medicine (2023) · PMID 37952131
- Wadden TA, Bailey TS, Billings LK, et al.. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity (STEP 3) · JAMA (2021) · PMID 33625476
- Rubino D, Abrahamsson N, Davies M, et al.. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial · JAMA (2021) · PMID 33755728
- Marso SP, Bain SC, Consoli A, et al.. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6) · New England Journal of Medicine (2016) · PMID 27633186
- Davies M, Færch L, Jeppesen OK, et al.. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial · The Lancet (2021) · PMID 33667417
- Garvey WT, Batterham RL, Bhatta M, et al.. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial · Nature Medicine (2022) · PMID 36216945
- Rubino DM, Greenway FL, Khalid U, et al.. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial · JAMA (2022) · PMID 35015037
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Can You Take Ipamorelin + Sermorelin With Tirzepatide or Semaglutide?, answered.
Yes, the paired vial can be prescribed alongside tirzepatide after a physician reviews your intake. No study has tested the combination. Appetite and glucose are the two things to watch.
The same reasoning applies. Semaglutide acts at the GLP-1 receptor and the paired vial at the GHRH and ghrelin receptors, so they do not overlap.
There is no evidence that it does. The sermorelin trials that measured weight found no change, and a mouse study of ipamorelin reported more food intake and fat. Tirzepatide is the one with the weight-loss evidence.
That is why it is added, but no trial shows a growth hormone secretagogue preserves lean mass during GLP-1 treatment. Protein and resistance training have the most behind them.
Some people report more appetite, because ipamorelin acts at the hunger hormone's receptor. With bedtime dosing it tends to land as you go to sleep. Report it if it interferes with your goal.
Neither has been tested with a GLP-1. Sermorelin alone avoids the ipamorelin appetite point, which is why a physician may prefer it for someone focused on weight.
Growth hormone reduces insulin sensitivity, so it can. Fasting glucose was unchanged in the published sermorelin trials. Your physician watches glucose across both medications.
Yes, as separate injections with separate syringes at different sites. Never mix the two in one syringe.
Follow each label. Pepti's typical directions for the paired vial are Monday through Friday nights at bedtime; tirzepatide is once weekly on a fixed day.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.